INS and Alzheimer disease: Concerning increased fasting plasma insulin, decreased CSF insulin levels, and/or decreased CSF/plasma insulin ratio in AD patients [11, 175], they are suggestive of insulin clearance impairment, which may elevate plasma Aβ levels [27, 274], due to the role of insulin in modulation of amyloid processing both in vivo and in vitro.